Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients

Clinical Rheumatology

Volumn 23, Issue 4, 2004, Pages 338-344

  Frank, Bernd ^a   Niesler, Beate ^a   Bondy, Brigitta ^b   Späth, Michael ^c   Pongratz, Dieter E ^c   Ackenheil, Manfred ^b   Fischer, Christine ^a   Rappold, Gudrun ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Fibromyalgia; HTR3A; HTR3B; Mutational analysis; Serotonin receptor genes

Indexed keywords

DNA; RECEPTOR SUBUNIT; SEROTONIN 3 RECEPTOR; SEROTONIN 3A RECEPTOR; SEROTONIN 3B RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DNA DENATURATION; DNA DETERMINATION; DNA SEQUENCE; FEMALE; FIBROMYALGIA; GENE MUTATION; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHARMACOGENETICS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 4444294796     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0927-2     Document Type: Article

References (43)

1. Hoyer D, Hannon JP, Martin GR (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 71:533-554
2. 3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 48:407-416
3. 3B subunit is a major determinant of serotonin receptor function. Nature 397:359-363
4. Parsons AA (1991) 5-HT receptors in human and animal cerebrovasculature. Trends Pharmacol Sci 12:310-315
5. Graeff FG (1997) Serotonergic systems. Psychiatr Clin North Am 20:723-739
6. Cavallini MC, Di Bella D, Catalano M, Bellodi L (2000) An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res 97:93-100
7. Moldofsky H (1982) Rheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin, and pain. Adv Neurol 33:51-57
8. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172
9. Eisinger J (2001) Seven steps to fibromyalgia. J Musculoskeletal Pain 9:3-122
10. Hudson JI, Pope HG (1994) The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 8:839-856
11. Ward NG, Bloom VL, Dworkin S, Fawcett J, Narasimhachari N, Friedel RO (1982) Psychobiological markers in coexisting pain and depression: toward a unified theory. J Clin Psychiatry 43:32-41
12. van Praag HM, Asnis GM, Kahn RS, Brown SL, Korn M, Friedman JM, Wetzler S (1990) Monoamines and abnormal behaviour. A multi-aminergic perspective. Br J Psychiatry 157:723-734
13. Almay BG, Von KL, Oreland L (1987) Platelet MAO in patients with idiopathic pain disorders. J Neural Transm 69:243-253
14. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J (1997) Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 24:555-559
15. Juhl JH (1998) Fibromyalgia and the serotonin pathway. Altern Med Rev 3:367-375
16. Schwarz MJ, Späth M, Muller-Bardorff H, Pongratz DE, Bondy B, Ackenheil M (1999) Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 259:196-198
17. Yunus MB (1998) Genetics in fibromyalgia syndrome. Z Rheumatol 57 [Suppl 2]:61-62
18. Offenbächer M, Bondy B, de Jonge S, Glatzeder K, Krüger M, Schoeps P, et al. (1999) Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 42:2482-2488
19. 2A-receptor gene in fibromyalgia. Neurobiol Dis 6:433-439
20. 3 receptor antagonists. Scand J Rheumatol 113 [Suppl]:37-45
21. Lautenschläger J, Brückle W, Schnorrenberger CC, Müller W (1988) Measuring pressure pain of tendons and muscles in healthy probands and patients with generalized tendomyopathy (fibromyalgia syndrome). Z Rheumatol 47:397-405
22. Dausset J, Cann H, Cohen D, Lathrop M, Lalouel J-M, White R (1990) CEPH: collaborative genetic mapping of the human genome. Genomics 6:575-578
23. den Dunnen JT, Antonarakis SE (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
24. Niesler B, Weiss B, Fischer C, Nöthen MM, Propping P, Bondy B, et al. (2001) Serotonin receptor gene HTR3A variants in schizophrenic and bipolar affective patients. Pharmacogenetics 11:21-27
25. Orita M, Suzuki Y, Sekiya T, Hayashi K (1989) Rapid and sensitive detection of point mutations and polymorphisms using the polymerase chain reaction. Genomics 5:874-879
26. Wallenstein S (1997) A non-iterative accurate asymptotic confidence interval for the difference between two proportions. Stat Med 16:1329-1336
27. Niesler B, Flohr T, Nöthen MM, Fischer C, Rietschel M, Franzek E, et al. (2001) Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder. Pharmacogenetics 11:471-475
28. Gutiérrez B, Arranz MJ, Huezo-Diaz P, Dempster D, Matthiasson P, Travis M, Munro J, Osborne S, Kerwin RW (2002) Novel mutations in 5-HT3A and 5-HT3B receptor genes not associated with clozapine response. Schizophr Res 58:93-97
29. Tremblay PB, Kaiser R, Sezer O, Rösler N, Schelenz C, Possinger K, Roots I, Brockmöller J (2003) Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol 21:2147-2155
30. Hayashi K (1992) PCR-SSCP: a method for detection of mutations. GATA 9:73-79
31. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
32. IA gene. Am J Med Genet 60:393-399
33. 7) receptor gene: genomic organization and systematic mutation screening in schizophrenia and bipolar affective disorder. Mol Psychiatry 1:392-397
34. 2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97:614-619
35. 1E) receptor protein points to its evolutionary conservation. Mol Brain Res 29:387-390
36. Shimron-Abarbanell D, Harms H, Erdmann J, Albus M, Maier W, Rietschel M, et al. (1996) Systematic screening for mutations in the human serotonin 1F receptor gene in patients with bipolar affective disorder and schizophrenia. Am J Med Genet 67:225-228
37. 5A receptor gene: systematic screening for DNA sequence variation and linkage mapping on chromosome 7q34-q36 using a polymorphism in the 5′ untranslated region. Biochem Biophys Res Commun 233:6-9
38. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, et al. (1999) Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231-238
39. Gursoy S (2002) Absence of association of the serotonin transporter gene polymorphism with the mentally healthy subset of fibromyalgia patients. Clin Rheumatol 21:194-197
40. Buskila D (2000) Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 12:113-123
41. Russell IJ (1998) Advances in fibromyalgia: possible role for central neurochemicals. Am J Med Sci 315:377-384
42. 3 receptor antagonists in various rheumatic diseases-a clue to the mechanism of action of these agents in fibromyalgia? Scand J Rheumatol 113 [Suppl]:66-71
43. 3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res 21:1-13